Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT-OSA: PAP vs Dental Device vs Atomoxetine-Oxybutynin for Sleep Apnea
NCT07679282Phase 4Recruiting
- Start
- Sep 2026
- Primary completion
- Mar 2030
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine, oxybutynin in obstructive sleep apnea (OSA). Started Sep 2026; status: recruiting.
02
Drugs
atomoxetineoxybutynin
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT07679282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07679282.